Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy
Clinical trial NCT02753686 · COMPLETED
Trial details
- NCT number
- NCT02753686
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-03-15
- Primary completion
- 2022-12-01
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.